Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia

NCT05621070 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

582

Enrollment

OTHER

Sponsor class

Conditions

Primary Hypercholesterolaemia and Mixed Dyslipidemia

Interventions

DRUG: JS002
DRUG: JS002
DRUG: Placebo
DRUG: Placebo

Sponsor

Shanghai Junshi Bioscience Co., Ltd.